Maximize the therapeutic impact and safely guide your clients who use psychedelics to treat their chronic pain. Apply the latest neuroscience while incorporating time-tested methods using our evidence-informed protocols.
Many clinicians and therapists are hearing from clients and other professionals that many chronic pain sufferers are starting to explore using psychedelics to treat their conditions. And you may even have clients that have had major symptom reduction, if not outright remission and you ask yourself “But I thought this was just for mental health issues; isn’t this just placebo?” Not if you understand the revolution in pain science that has been occurring the last two decades simultaneous to the explosion of research in psychedelic science.
Our introductory seminar will introduce you to the basics of pain neuroscience, the history and current developments within clinical psychedelic research, and how both are employing nearly identical neuroplastic changes in the brain to create profound relief for their clients.
“Overall, the workshop was REALLY good. It covered the history, the evolution of research on psychedelics, different psychedelics for pain, and for different conditions. All of the content was really good...I really thought the models of pain and phantom limb stuff as well as highlighting to analogous nature or physical and emotional/psychological pain was well done.”
“Thanks Court for putting this seminar together and sharing it. I have been looking for something in a video format that consolidates all things in terms of therapy via psychedelics, and your course is the best I’ve found so far. A presentation of your coursework literally left my instructors’ jaws hung.”
“It was a pleasure to attend the invitation-only Psychedelics and Pain Symposium. I left curious about new research avenues and inspired by the dedicated group of scientists in this space. Thank you to Court for hosting, and I’m looking forward to more!”
Courses
Psychedelics and Pain Symposium
June 25, 2022: REPLAY
This was the first public Psychedelics and Pain Symposium, presented by REMAP Therapeutics, along with our co-sponsors Psychedelics Today and ClusterBusters, Inc. It featured several top researchers in the field of pain and psychedelics presenting past and current research. (Note: unfortunately Dr. Gül Dölen was unable to attend at the last minute.)
Running time approximately 5 hours 30 minutes.
Additionally, we had discussions with attendees around the formation of the Psychedelics and Pain Association, a nonprofit organization for practitioners and participants; and REMAP Research Retreats, offering psychedelic retreats for those in pain while collaborating on data sharing with research universities and institutions using the best evidence-informed practices.
